Inluriyo
Payments companies reported to CMS as associated with Inluriyo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Inluriyo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Inluriyo
These are the largest totals companies reported as associated with Inluriyo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Abhishek Patel | Glendale, AZ | Hematology & Oncology | $83.75 |
| Jori Kaplan | Phoenix, AZ | Hematology & Oncology | $83.75 |
| Chelsea Henriques | Phoenix, AZ | Acute Care (Nurse Practitioner) | $83.75 |
| David Ellison | Charleston, SC | Hematology & Oncology | $27.56 |
| Mary Macdonald | Charleston, SC | Medical | $27.56 |
| Corin Jaynes | Charleston, SC | Physician Assistant | $27.56 |
| Ashley Mackintosh | Charleston, SC | Physician Assistant | $27.56 |
| Gene Saylors | Charleston, SC | Medical Oncology | $27.56 |
| Diane Burdsal | Charleston, SC | Nurse Practitioner | $27.56 |
| Heather Cheek | Charleston, SC | Medical | $27.56 |
Prescribed Inluriyo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.